Enjoy complimentary customisation on priority with our Enterprise License!
The Orthobiologics Market size is estimated to grow by USD 2.64 billion between 2022 and 2027, accelerating at a CAGR of 7.88% during the forecast period. The market's growth is influenced by various factors, including the increasing prevalence of orthopedic disorders, especially among the aging population. Additionally, there is a growing focus on reducing orthopedic surgeries, and the market is witnessing a rise in approvals and clearances for such products. However, the market faces challenges, such as high costs and inadequate reimbursements for such products and procedures, concerns associated with their use, and stringent regulations. Despite these challenges, the market is experiencing positive trends, including the development of new products, emerging technological innovations, and the rising popularity of orthobiologics.
To learn more about this report, Request Free Sample
This market research report extensively covers market segmentation by application (spinal fusion, reconstructive surgery, trauma repair, and others), product (bone graft substitutes, viscosupplementation, and stem cells), and geography (North America, Europe, Asia, and the Rest of World (ROW)).
The market share by the spinal fusion segment will be significant during the forecast period. Spinal fusion or spinal arthrodesis is a technique that permanently joins two or more vertebrae in the spine to increase stability, repair a deformity, or relieve discomfort. Patients with spinal disorders such as spinal abnormalities, spinal weakness or instability, and herniated discs can benefit from this therapy. As a result, orthobiologics improve the efficacy of spinal fusion surgeries by healing the targeted site. Such orthobiologic advantages in spinal fusion procedures will drive orthobiologic demand over the projection period.
Get a glance at the market contribution of various segments Request a PDF Sample
The spinal fusion segments show a gradual increase in the market share of USD 2.31 billion in 2017. The higher prevalence of spine-related issues is anticipated to drive the spine fusion application segment in the market. Scoliosis affects 2-3 percent of the population, or around six to nine million persons in the United States, according to data from the National Scoliosis Foundation. People in their thirties and fifties are more prone to it. Above mentioned spinal disorders are generally treated with spinal fusion procedures. Thus, a higher prevalence of such diseases is expected to boost the growth of the spinal fusion segment in the market.
For more insights on the market share of various regions Request PDF Sample now!
North America is estimated to contribute 41% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. North America dominated the market and is expected to maintain its position during the projection period due to the presence of a well-established healthcare system that provides high-quality orthobiologics. Obesity and an increase in the prevalence of arthritis have increased the demand for minimally invasive procedures such as bone grafting. The increase in sports injuries across North America is also a major factor driving the market.
The market thrives at the intersection of regenerative medicine and orthopedic procedures, offering solutions for various conditions like bone diseases, tumors, and infections. These treatments address traumas, fractures, and lesions, promoting healing and regeneration. Utilizing biocomposites and bone morphogenetic proteins, companies like Prosidyan and Fibergaft develop innovative bone graft substitutes. These products find application in hospitals, ASCs, and specialty clinics, catering to diverse needs like maxillofacial fractures and injuries from automobile accidents and sports. They aid in pain management and rehabilitation, catering to patients with chronic illnesses and aiding in recovery from joint and muscle injuries. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The increasing prevalence of orthopedic disorders coupled with an aging population is a key factor in the growth of the market. There has been an increase in the number of orthopedic disorders across the world over the last decade. Limited physical activity and eating habits can negatively influence the body's homeostasis. This issue worsens with age, putting most persons aged 60 and up vulnerable to orthopedic disorders such as arthritis. Further, orthobiologics, including fibergaft bone graft substitutes, play a vital role in treating bone tumors, infections, bone lesions, and bone fractures, offering innovative solutions to enhance bone healing and regeneration in orthopedic procedures.
Further, orthobiologic products utilized by sports science physicians offer innovative solutions for treating joint injuries, providing alternatives to traditional pain medication and facilitating natural healing processes in orthopedic care. According to the CDC, approximately 65.6% of persons aged 65 and up will visit dental surgeons in 2023. Due to the rise in the prevalence of orthopedic problems, orthobiologics are required for the fixation or binding of joint disorders. Thus, the increasing number of orthopedic disorders will increase the demand and thus drive market growth.
The increase in the development of new products is a key trend in the market's growth. These product launches will encourage other market players to invest in developing advanced products to maintain their position in the market. Therefore, the introduction of new products will support the revenue inflow in the market during the forecast period. Many companies offering orthobiologics, such as SeaSpine Holdings Corp and Bioventus LLC, are focusing on the development of new products to cater to customers with specific requirements.
Furthermore, the rise in popularity of orthobiologics will drive market growth. Orthobiologics therapy focuses on using the healing and rejuvenating properties of the body's own cells for the repair of damaged tissues. Some of the innovative orthobiologics options which are helpful in the treatment of osteoarthritis include platelet-rich plasma (PRP), adipose tissue-derived mesenchymal stem cells (ADMSC), bone marrow concentrate (BMC), autologous chondrocyte implantation (ACI), and autologous conditioned serum. The availability of such products has resulted in preventing operative procedures such as knee arthroplasty for the treatment of osteoarthritis. This, in turn, is anticipated to boost the growth of the market over the forecast period.
The high costs and inadequate reimbursements for products and procedures are major challenges to the market growth. The growing geriatric population, combined with a growth in the number of orthopedic illnesses, has boosted the demand. Advanced ortho biologics products are widely available on the market, particularly in developed countries like the United States. However, the expensive cost of these products prevents them from being widely adopted in emerging and underdeveloped economies.
For instance, reimbursement is complex in the US due to stringent FDA regulations and the multi-payor system. The high costs of such products, such as new bone grafts, also make reimbursement challenging, leading to low adoption rates in economically depressed countries. Therefore, for manufacturers to be successful, the development of a comprehensive plan for reimbursement before obtaining FDA approval becomes essential. The impact of these factors, however, is expected to reduce in the near future, as many manufacturers are planning to develop affordable products.
The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market forecasting report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Market Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Advanced Medical Solutions Group Plc: The company offers orthobiologics solutions that include synthetic bone substitutes, collagen membranes, and bioabsorbable screws.
The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market analysis report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
The market is thriving due to the rising prevalence of bone infections and musculoskeletal diseases. With innovations like stem cell-based allografts and viscosupplements, patients are benefiting from improved treatment options. Procedures such as total knee replacement and soft tissue repair are facilitated by advancements in bone growth factors and cellular allografts. Companies like Depuy Synthes are at the forefront of providing solutions for shoulder, knee, and elbow injuries. However, challenges like the coronavirus pandemic and backlog of surgeries due to elective surgery delays impact the market dynamics, affecting orthopedic patients and senior persons alike.
Additionally, the market plays a pivotal role in addressing a wide range of orthopedic conditions. From bone injuries to shoulder injuries and knee osteoarthritis, orthobiologics offer innovative solutions for patients. Utilizing advanced treatments such as Demineralized Bone Matrix (DBM) and Bmp-based treatments, orthopedic surgeons can perform reconstructive and fracture surgery with improved outcomes. Additionally, orthobiologics contribute to the treatment of hip and backbone fractures, catering to patients in Hospitals & Ambulatory Surgical Centers (ASCs). Despite challenges like the coronavirus pandemic and PPE shortages, orthobiologics continue to enhance patient care and non-surgical treatment options.
Market Scope |
|
Report Coverage |
Details |
Page number |
169 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7.88% |
Market growth 2023-2027 |
USD 2.64 billion |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
6.95 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 41% |
Key countries |
US, Canada, UK, Germany, and China |
Competitive landscape |
Leading companies, Market Positioning of companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Advanced Medical Solutions Group Plc, Anika Therapeutics Inc., Bioventus LLC, Globus Medical Inc., Integra Lifesciences Holdings Corp., Johnson and Johnson, Kuros Biosciences AG, Medtronic Plc, MTF Biologics, Nuvasive Inc, Orthofix Medical Inc., OrthoPediatrics Corp., ROYAL BIOLOGICS, RTI Surgical Inc., SeaSpine Holdings Corp., Smith and Nephew plc, Stryker Corp., Xtant Medical Inc., Zimmer Biomet Holdings Inc., and Arthrex Inc. |
Market dynamics |
Parent Market Analysis; Market growth inducers and obstacles; Fast-growing, market report, and slow-growing segment analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.